Cargando…
P216 The impact of the COVID-19 pandemic and elexacaftor/tezacaftor/ivacaftor initiation on high-cost medication utilisation in adults living with cystic fibrosis
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Cystic Fibrosis Society. Published by Elsevier B.V.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250896/ http://dx.doi.org/10.1016/S1569-1993(23)00589-1 |
| _version_ | 1785055857787011072 |
|---|---|
| author | Suhel, M.S. Chan, A. Nazareth, D. Wat, D. Walshaw, M.J. Green, D. Frost, F. |
| author_facet | Suhel, M.S. Chan, A. Nazareth, D. Wat, D. Walshaw, M.J. Green, D. Frost, F. |
| author_sort | Suhel, M.S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10250896 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | European Cystic Fibrosis Society. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102508962023-06-09 P216 The impact of the COVID-19 pandemic and elexacaftor/tezacaftor/ivacaftor initiation on high-cost medication utilisation in adults living with cystic fibrosis Suhel, M.S. Chan, A. Nazareth, D. Wat, D. Walshaw, M.J. Green, D. Frost, F. J Cyst Fibros Posters European Cystic Fibrosis Society. Published by Elsevier B.V. 2023-06 2023-06-09 /pmc/articles/PMC10250896/ http://dx.doi.org/10.1016/S1569-1993(23)00589-1 Text en Copyright © 2023 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Posters Suhel, M.S. Chan, A. Nazareth, D. Wat, D. Walshaw, M.J. Green, D. Frost, F. P216 The impact of the COVID-19 pandemic and elexacaftor/tezacaftor/ivacaftor initiation on high-cost medication utilisation in adults living with cystic fibrosis |
| title | P216 The impact of the COVID-19 pandemic and elexacaftor/tezacaftor/ivacaftor initiation on high-cost medication utilisation in adults living with cystic fibrosis |
| title_full | P216 The impact of the COVID-19 pandemic and elexacaftor/tezacaftor/ivacaftor initiation on high-cost medication utilisation in adults living with cystic fibrosis |
| title_fullStr | P216 The impact of the COVID-19 pandemic and elexacaftor/tezacaftor/ivacaftor initiation on high-cost medication utilisation in adults living with cystic fibrosis |
| title_full_unstemmed | P216 The impact of the COVID-19 pandemic and elexacaftor/tezacaftor/ivacaftor initiation on high-cost medication utilisation in adults living with cystic fibrosis |
| title_short | P216 The impact of the COVID-19 pandemic and elexacaftor/tezacaftor/ivacaftor initiation on high-cost medication utilisation in adults living with cystic fibrosis |
| title_sort | p216 the impact of the covid-19 pandemic and elexacaftor/tezacaftor/ivacaftor initiation on high-cost medication utilisation in adults living with cystic fibrosis |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250896/ http://dx.doi.org/10.1016/S1569-1993(23)00589-1 |
| work_keys_str_mv | AT suhelms p216theimpactofthecovid19pandemicandelexacaftortezacaftorivacaftorinitiationonhighcostmedicationutilisationinadultslivingwithcysticfibrosis AT chana p216theimpactofthecovid19pandemicandelexacaftortezacaftorivacaftorinitiationonhighcostmedicationutilisationinadultslivingwithcysticfibrosis AT nazarethd p216theimpactofthecovid19pandemicandelexacaftortezacaftorivacaftorinitiationonhighcostmedicationutilisationinadultslivingwithcysticfibrosis AT watd p216theimpactofthecovid19pandemicandelexacaftortezacaftorivacaftorinitiationonhighcostmedicationutilisationinadultslivingwithcysticfibrosis AT walshawmj p216theimpactofthecovid19pandemicandelexacaftortezacaftorivacaftorinitiationonhighcostmedicationutilisationinadultslivingwithcysticfibrosis AT greend p216theimpactofthecovid19pandemicandelexacaftortezacaftorivacaftorinitiationonhighcostmedicationutilisationinadultslivingwithcysticfibrosis AT frostf p216theimpactofthecovid19pandemicandelexacaftortezacaftorivacaftorinitiationonhighcostmedicationutilisationinadultslivingwithcysticfibrosis |